Summary
An in-depth analysis of clinical and laboratory findings in 58 patients affected by hereditary angioneurotic edema (HANE) is reported with special focus on problems related to the diagnosis of the disorder. The functional C1 inhibitor (C1INH) assay is the method of choice in the diagnosis of HANE, as it is capable of revealing the disorder with 100% accuracy. The immunochemical assay of C1INH detected HANE in 84.5% of the cases, i.e., immunochemical deficiency of C1INH (type I HANE). C4 was markedly reduced in both type I and type II HANE; thus, C4 levels can be particularly useful when C1INH functional tests are not available. CH50 testing is of little diagnostic value since total hemolytic complement activity is reduced in a variety of other congenital or acquired pathologies involving the complement system. The CH50 assay after incubation in low ionic strength buffer may be utilized in mass screening programs for qualitative evaluation. However, the test has the drawback of not being applicable in cases of frank hypocomplementemia. While a depletion of the complement classical pathway was detected in most cases, no alteration in the complement alternative pathway was recorded, nor there was any reduction in immunoglobulin levels. Family history was positive in 100% of the cases. Attacks were almost always brought on by stress and/or trauma, though the causes were sometimes unknown. Edema could be cutaneous (non-pitting and non-pruritic) in 94.2%, laryngeal (often life-threatening) in 48% and abdominal (almost always painful) in 88.4% of patients. Associated pathologies were found in 2 patients, i.e., lupus rash and C3NeF-positive chronic membranoproliferative glomerulonephritis, respectively.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Agostoni A., Marasini B., Cicardi M., Martignoni G. C., Brenna O.: Studio mediante dosaggio enzimatico e immunochimico dell’inibitore della C1 esterasi in 50 pazienti affetti da angioedema ereditario — Boll. Ist. sieroter. milan.56, 1, 1977.
Bock S. C., Skriver K., Nielsen E., Thogersen H.-C., Wiman B., Donaldson V. H., Eddy R. L., Marrinan J., Radziejewska E., Huber R., Shows T. B., Magnusson S.: Human C1 inhibitor: primary structure, cDNA cloning, and chromosome localization — Biochemistry25, 4292, 1986.
Brown D. L.: Complement and coagulation — Progr. Immunol.191, 1, 1974.
Carbonara A. O., Meo T., De Marchi M.: Immunogenetica del complemento. In:Serafini U. (Ed.): Il sistema complementare nella clinica. Collana di immunologia clinica, vol. I. Leonardo Ed. Sci., Roma, 1977; p. 1.
Cicardi M., Bergamaschini L., Marasini B., Boccasini G., Tucci A., Agostoni A.: Hereditary angioedema: an appraisal of 104 cases — Amer. J. med. Sci.284, 48, 1982.
Cullmann W., Kovary P. M., Muller N., Dick W.: Complement, coagulation and fibrinolytic parameters in hereditary angioedema (HAE) — Clin. exp. Immunol.49, 618, 1982.
Davis A. E., III,Whitehead A. S., Harrison R. A., Dauphinais A., Bruns G. A. P., Cicardi M., Rosen F. S.: Human inhibitor of the first component of complement, C1: characterization of cDNA clones and localization of the gene to chromosome 11 — Proc. nat. Acad. Sci. (Wash.)83, 3161, 1986.
De Marchi M., Jacot-Guillarmod H., Ressa T. G., Carbonara A. O.: Hereditary angioedema: report of a large kindred with a rare genetic variant of C1-esterase inhibitor — Clin. Genet.4, 229, 1973.
Des Prez R. M., Bryan C. S., Hawiger J.: Function of the classical and alternate pathways of human complement in serum treated with ethylene-glycol tetraacetic acid — Infect Immun.11, 1235, 1975.
Donaldson V. H.: Mechanism of activation of C1 esterase in hereditary angioneurotic oedema plasmain vitro: the role of Hageman factor, a clot-promoting agent — J. exp. Med.127, 411, 1968.
Donaldson V. H., Evans R. R.: A biochemical abnormality in hereditary angioneurotic edema — Amer. J. Med.35, 37, 1963.
Donaldson V. H., Harrison R. A.: Complexes between C1-inhibitor, kallikrein, high molecular weight kininogen, plasma thromboplastin antecedent, and plasmin on normal human plasma and hereditary angioneurotic edema plasmas containing dysmorphic C1-inhibitors: role of cold activation — Blood60, 121, 1982.
Donaldson V. H., Merler E., Rosen F. S.: A polypeptide kinin in hereditary angioneurotic edema plasma: role of complement in its formation — J. Lab. clin. Med.76, 986, 1970.
Donaldson V. H., Ratnoff O. D., Klemperer M. R.: Studies on a peptide from hereditary angioneurotic edema plasma with permeability factor and kinin activity — J. Immunol.101, 818, 1968.
Fong J. S. C., Good R. A., Gewurz H.: A simple diagnostic test for hereditary angioneurotic edema — J. Lab. clin. Med.75, 836, 1970.
Fontana L., De Carolis C., Perricone R.: Il complemento. In:Serafini U. (Ed.): Immunologia clinica ed allergologia. USES, Firenze, 1982; p. 219.
Fontana L., Gandolfo G. M., Amoroso A., Ferri G. M., Lioy E.: Rapporti fra coagulazione e complemento. In:Serafini U. (Ed.): Il sistema complementare nella clinica. Collana di immunologia clinica, vol. I. Leonardo Ed. Sci., Roma, 1977; p. 19.
Fontana L., Perricone R.: Sulla patogenesi dell’edema angioneurotico ereditario — Folia allergol. (Roma)27, 59, 1980.
Fontana L., Perricone R.: Sulla diagnosi e terapia dell’edema angioneurotico ereditario — Folia allergol. (Roma)28, 83, 1981.
Fontana L., Perricone R., De Carolis C., Mazzarella V., Taccone-Gallucci M., Casciani C. U.: Dialysis leukopenia and hypoxemia in a patient without measurable complement activity — La Ricerca Clin. Lab.15, 331, 1985.
Forsgren A., McLean R. H., Michael A. F.: Studies on the alternate pathway in chelated serum — J. Lab. clin. Med.85, 904, 1975.
Frank M. M., Gelfand J. A., Atkinson J. P.: Hereditary angioedema: the clinical syndrome and its management — Ann. intern. Med.84, 580, 1976.
Kaplan A. P., Vogt W.: Relation of complement with other plasma enzyme systems — progr. Immunol.305, 1, 1974.
Klemperer M. R., Donaldson V. H., Rosen F. S.: Effect of C1 esterase on vascular permeability in man: studies in normal and complement-deficient individuals and in patients with hereditary angioneurotic edema — J. clin. Invest.47, 604, 1968.
Lachmann P. J., Hobart M. J., Aston W. P.: Complement technology. In:Weir D. M. (Ed.): Handbook of experimental immunology. Blackwell Sci. Publ., Oxford, 1974; vol. 1, chapt. 5, p. 1.
Mancini G., Carbonara A. O., Heremans J. F.: Immunochemical quantitation of antigens by single radial immunodiffusion — Immunochemistry2, 235, 1965.
Mayer M. M.: Complement and complement fixation. In:Kabat E. A., Mayer M. M. (Eds): Experimental immunochemistry. 2nd ed., C. C. Thomas Publ., Springfield, Ill., 1961; p. 133.
Osler W.: Hereditary angio-neurotic edema — Amer. J. med. Sci.95, 362, 1887.
Perricone R., De Carolis C., Grimaldi O., Fontana L.: Activation of human complement by crude and purified antigens fromEchinococcus granulosus — La Ricerca Clin. Lab.14, 65, 1984.
Perricone R., Fontana L., De Carolis C., Carini C., Sirianni M. C., Aiuti F.: Evidence for activation of complement in patients with AIDS-related complex (ARC) and/or lymphadenopathy syndrome (LAS) — Clin. exp. Immunol.70, 500, 1987.
Platts-Mills T. A. E., Ishizaka K.: Activation of the alternative pathway of human complement by rabbit cells — J. Immunol.113, 348, 1974.
Quincke H.: Ueber akutes umschriebenes Hautoedem — Mh. prakt. Dermatol.1, 129, 1882.
Rapp H. J., Borsos T.: Molecular basis of complement action. Appleton-Century-Crofts, New York, 1970; p. 75.
Ratnoff O. D.: Some relationship among hemostasis, fibrinolytic phenomena, immunity and inflammatory response — Advanc. Immunol.10, 145, 1969.
Rosen F. S., Charache P., Pensky J.: Hereditary angioneurotic edema: two genetic variants — Science148, 957, 1965.
Stoppa-Lyonnet D., Tosi M., Laurent J., Sobel A., Lagrue G., Meo T.: Altered C1 inhibitor genes in type I hereditary angioedema — New Engl. J. Med.317, 1, 1987.
Strubing P.: Ueber akutes (angioneurotisches) Oedem — Z. klin. Med.9, 381, 1885.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Fontana, L., Perricone, R., De Carolis, C. et al. Hereditary angioneurotic edema: Clinical and laboratory findings in 58 subjects. Res. Clin. Lab. 19, 51–58 (1989). https://doi.org/10.1007/BF02871792
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02871792